Latest Regulatory News

Life360 has announced a $250 million convertible senior notes offering, with an option for an additional $37.5 million, aiming to bolster its balance sheet and support strategic initiatives.

Lincoln Minerals has revealed a sophisticated multi-phase copper-base metals system at its Minbrie Project in South Australia, following a detailed re-logging and assay program. With laboratory results pending, the company is gearing up for targeted drilling in the second half of 2025.

Mithril Silver and Gold has acknowledged undisclosed channel sample results at its El Apomal target, explaining recent unusual trading activity. The company has entered a trading halt ahead of a formal announcement expected by 3 June 2025.

Alvo Minerals has updated its entitlement offer to include free attaching options, aiming to raise $1.56 million to fund exploration and working capital. The offer targets eligible shareholders with a $0.02 share price and options exercisable at $0.05 over three years.

Inoviq Ltd's trading suspension has been lifted following new disclosures, but the ASX continues to investigate the company's compliance with listing rules.

INOVIQ Limited has revealed promising data for its EXO-OC™ ovarian cancer screening test, demonstrating exceptional accuracy and flawless detection of early-stage cancers. This innovation could transform early diagnosis and treatment outcomes for women worldwide.

Loyal Lithium Limited remains suspended from ASX trading after missing its deadline to disclose details of a proposed acquisition and respond to a price query, raising fresh questions about the company’s compliance and strategic direction.

James Hardie Industries is set to terminate its American Depositary Share program following its merger with The AZEK Company and direct NYSE listing, simplifying its share structure for investors.

James Hardie Industries has successfully syndicated $3.5 billion in new credit facilities, providing robust financial backing for its planned merger with The AZEK Company Inc. This move significantly reduces prior bridge loan commitments and enhances the company’s financial flexibility.

Cardiex Limited has gained Therapeutic Goods Administration approval for its CONNEQT Pulse device, paving the way for commercial expansion in Australia alongside its established US presence.

Vinyl Group Ltd has voluntarily suspended trading on the ASX pending a Federal Court decision on its application for relief after failing to lodge required cleansing notices on time.

Bio-Gene Technology Limited has raised $338,500 through a Share Purchase Plan, contributing to a total capital raise of $2.45 million to advance its bio-insecticide products.